Experimental anti-tumor therapy in 3-D: Spheroids - old hat or new challenge?

被引:352
作者
Friedrich, Juergen
Ebner, Reinhard
Kunz-Schughart, Leoni A.
机构
[1] Tech Univ Dresden, Fac Med Carl Gustav Carus, Ctr Radiat Res Oncol, D-01307 Dresden, Germany
[2] Univ Regensburg, Inst Pathol, D-8400 Regensburg, Germany
[3] Avalon Pharmaceut Inc, Germantown, MD USA
关键词
3-D culture; multicellular tumor spheroids; anti-tumor therapy;
D O I
10.1080/09553000701727531
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Purpose: To give a state-of-the-art overview on the promise of three-dimensional ( 3-D) culture systems for anticancer drug development, with particular emphasis on multicellular tumor spheroids ( MCTS). Results and conclusions: Cell-based assays have become an integral component in many stages of routine anti-tumor drug testing. However, they are almost always based on homogenous monolayer or suspension cultures and thus represent a rather artificial cellular environment. 3-D cultures - such as the well established spheroid culture system - better reflect the in vivo behavior of cells in tumor tissues and are increasingly recognized as valuable advanced tools for evaluating the efficacy of therapeutic intervention. The present article summarizes past and current applications and particularly discusses technological challenges, required improvements and recent progress with the use of the spheroid model in experimental therapeutics, as a basis for sophisticated drug/therapy screening. A brief overview is given focusing on the nomenclature of spherical 3-D cultures, their potential to mimic many aspects of the pathophysiological situation in tumors, and currently available protocols for culturing and analysis. A list of spheroid-forming epithelial cancer cell lines of different origin is provided and the recent trend to use spheroids for testing combination treatment strategies is highlighted. Finally, various spheroid co-culture approaches are presented that have been established to study heterologous cell interactions in solid tumors and thereby are able to reflect the cellular tumor environment with increasing accuracy. The intriguing observation that in order to retain certain tumor initiating cell properties, some primary tumor cell populations must be maintained exclusively in 3-D culture is mentioned, adding a new but fascinating challenge for future therapeutic campaigns.
引用
收藏
页码:849 / 871
页数:23
相关论文
共 260 条
[1]   COMPARATIVE PO2 MEASUREMENTS IN CELL SPHEROIDS CULTURED WITH DIFFERENT TECHNIQUES [J].
ACKER, H ;
CARLSSON, J ;
MUELLERKLIESER, W ;
SUTHERLAND, RM .
BRITISH JOURNAL OF CANCER, 1987, 56 (03) :325-327
[2]  
AUDRAN R, 1994, CANCER IMMUNOL IMMUN, V39, P299, DOI 10.1007/s002620050129
[3]   Evolution of anticancer drug discovery and the role of cell-based screening [J].
Balis, FM .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (02) :78-79
[4]  
Ballangrud ÅM, 1999, CLIN CANCER RES, V5, p3171S
[5]  
Ballangrud ÅM, 2001, CANCER RES, V61, P2008
[6]  
BANKS SD, 1994, CANCER CHEMOTH PHARM, V33, P455
[7]   USE OF MULTICELL SPHEROIDS OF OVARIAN-CARCINOMA AS AN INTRAPERITONEAL RADIO-IMMUNOTHERAPY MODEL - UPTAKE, RETENTION KINETICS AND DOSIMETRIC EVALUATION [J].
BARDIES, M ;
THEDREZ, P ;
GESTIN, JF ;
MARCILLE, BM ;
GUERREAU, D ;
FAIVRECHAUVET, A ;
MAHE, M ;
SAIMAUREL, C ;
CHATAL, JF .
INTERNATIONAL JOURNAL OF CANCER, 1992, 50 (06) :984-991
[8]   A more aggressive breast cancer spheroid model coupled to an electronic capillary sensor system for a high-content screening of cytotoxic agents in cancer therapy:: 3-dimensional in vitro tumor spheroids as a screening model [J].
Bartholomä, P ;
Impidjati ;
Reininger-Mack, A ;
Zhang, ZH ;
Thielecke, H ;
Robitzki, A .
JOURNAL OF BIOMOLECULAR SCREENING, 2005, 10 (07) :705-714
[9]   Selection of chemotherapy by ex vivo assessment of tumor sensitivity to cytotoxic drugs [J].
Berglund, Å ;
Glimelius, B ;
Bergh, J ;
Brodin, O ;
Fjällskog, ML ;
Hagberg, H ;
von Heideman, A ;
Larsson, R ;
Tholander, B ;
de la Torre, M ;
Åström, G ;
Öberg, K ;
Parö, G ;
Nygren, P .
MEDICAL ONCOLOGY, 2002, 19 (03) :151-159
[10]   Engineering cellular microenvironments to cell-based drug testing improve [J].
Bhadriraju, K ;
Chen, CS .
DRUG DISCOVERY TODAY, 2002, 7 (11) :612-620